UBS Recommends Overweight on Chinese Stocks for 2025.

3 hours ago7 min read1 comments

In a decisive move that cuts against the grain of prevailing market anxiety, UBS has thrown its considerable weight behind Chinese equities, formally recommending an 'overweight' position for 2025. This bullish stance, emerging from the bank's global wealth management arm, isn't made in a vacuum; it's a calculated bet on a confluence of three powerful drivers that UBS analysts believe will propel the market forward.First and foremost are the undeniably attractive valuations. After years of underperformance driven by a perfect storm of regulatory crackdowns, property sector crises, and geopolitical tensions, Chinese stocks are trading at a significant discount to their historical averages and to other major global markets.This valuation gap presents a compelling entry point for investors who have been waiting on the sidelines for a signal that the risk-reward calculus has shifted. The second pillar of this thesis is the expectation of solid and sustained fund flows.As global investors, particularly large institutional allocators, rebalance their portfolios for the new year, the sheer scale of capital that could be redirected towards a market of China's size is immense. We've already seen glimpses of this, with episodic bursts of foreign buying on days when positive policy news emerges.UBS anticipates this trickle will become a steadier stream as confidence builds. The third and perhaps most critical factor is the presence of what they term 'favourable macro catalysts.' This is a polite way of saying that the Chinese government, after a period of stringent zero-COVID policies and regulatory purges that rattled international capital, is now pivoting decisively towards stimulus. We've seen a series of measured but meaningful interventions: interest rate cuts, targeted support for the beleaguered property sector, and a clear rhetorical shift towards stabilizing and growing the economy.The Politburo is now openly discussing 'high-quality development,' a phrase that signals a more balanced approach between ideological goals and economic pragmatism. This is not to say the path will be smooth.The broader emerging market landscape, as UBS notes, is expected to deliver slower returns after an initial period of outperformance. The MSCI Emerging Markets Index, the benchmark for the asset class, is projected to see its earnings per share (EPS) growth decelerate from a robust 18% in 2025 to 15% in 2026 and just 10% in 2027.This deceleration underscores the importance of stock-picking and regional allocation. China, with its unique cycle of policy-driven recovery, is positioned to potentially outperform this broader EM deceleration.The artificial intelligence revolution, while a global phenomenon, also presents a specific opportunity for China. While it may lag the U.S. in foundational model development, its prowess in manufacturing and hardware, coupled with a massive domestic market for AI applications in industry and consumer tech, provides a runway for growth that is not fully priced in.For investors, this UBS call is reminiscent of Warren Buffett's famous adage about being 'fearful when others are greedy and greedy when others are fearful. ' The pervasive fear regarding China has been palpable for years, but UBS is making the case that the fundamentals are now aligning for a period of mean reversion. It’s a bet on a cyclical recovery supercharged by policy, a play that requires looking past the headlines and focusing on the cold, hard numbers of valuation, earnings potential, and the directional shift in macroeconomic management from Beijing.

#emerging markets

#China stocks

#UBS

#earnings growth

#AI

#featured